Concepedia

Author

YoungJoon Park

CHA UniversityORCID

Also Known As

Young Joon Park, Young-Joon Park, YoungJoon Park

87

Publications

493

Citations

12

H-Index

14

Concepts

All Affiliations

CHA UniversityYeungnam UniversitySamil Pharm (South Korea)CHA University Bundang Medical CenterSeoul National University
YP

About

YoungJoon Park is an author at CHA University specializing in medicine, medicinal chemistry, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

57

2

Public Health

1

1

41

3

Biology

1

1

41

4

Materials Science

1

1

24

5

Pharmacology

1

1

16

YoungJoon Park

×

13

Publications

473

Citations

12

H-Index

YearCitations

Highly efficient gene silencing and bioimaging based on fluorescent carbon dots in vitro and in vivo

Seongchan Kim, Yuri Choi, Ginam Park,

Nano Research

2016

77

Physicochemical characterization and in vivo evaluation of flurbiprofen-loaded solid dispersion without crystalline change

Dong Hoon Oh, YoungJoon Park, Jun Heok Kang,

Drug Delivery

2010

55

Grifola frondosa water extract alleviates intestinal inflammation by suppressing TNF-α production and its signaling

Jong Suk Lee, Su-Young Park, Dinesh Thapa,

Experimental & Molecular Medicine

2010

51

Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC

Seung Yeon Oh, You Won Lee, Eun Ji Lee,

Clinical Cancer Research

2022

46

Upregulation of the NLRC4 inflammasome contributes to poor prognosis in glioma patients

Jaejoon Lim, Min Jun Kim, YoungJoon Park,

Scientific Reports

2019

42

Comparative genomic analysis of the human and nematode<i>Caenorhabditis elegans</i>uncovers potential reproductive genes and disease associations in humans

Yong-Soon Kim, YoungJoon Park, JoonYeon Hwang,

Physiological Genomics

2018

41

A Disintegrin and Metalloproteinase 9 (ADAM9) in Advanced Hepatocellular Carcinoma and Their Role as a Biomarker During Hepatocellular Carcinoma Immunotherapy

Sooyeon Oh, YoungJoon Park, Hyun-Jung Lee,

Cancers

2020

37

Autologous adoptive immune-cell therapy elicited a durable response with enhanced immune reaction signatures in patients with recurrent glioblastoma: An open label, phase I/IIa trial

Jaejoon Lim, YoungJoon Park, Ju Won Ahn,

PLoS ONE

2021

34

MD001, a Novel Peroxisome Proliferator-activated Receptor α/γ Agonist, Improves Glucose and Lipid Metabolism

Seok-Ho Kim, Shin Hee Hong, YoungJoon Park,

Scientific Reports

2019

25

Development of novel itraconazole-loaded solid dispersion without crystalline change with improved bioavailability

YoungJoon Park, Jing Ji Xuan, Dong Hoon Oh,

Archives of Pharmacal Research

2010

24

Page 1